http://orcid.org/0000-0002-9850-9520
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, Frederico LA Fernandes, Jorge Dreyse, José R Jardim, Siwasak Juthong, Gur Levy & Martin Sivori. (2023) Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1853-1866.
Read now
Read now
Marc Miravitlles, Katia Verhamme, Peter M A Calverley, Michael Dreher, Valentina Bayer, Asparuh Gardev, Alberto de la Hoz, Jadwiga Wedzicha & David Price. (2022) A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 545-558.
Read now
Read now
Bernardino Alcázar-Navarrete, Francisco García-Rio, Guadalupe Sánchez, Esther Mariscal, Andrea García, Maribel Cuesta, Estefany Uría & Marc Miravitlles. (2021) Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2149-2161.
Read now
Read now
Peter J. Barnes. (2021) Endo-phenotyping of COPD patients. Expert Review of Respiratory Medicine 15:1, pages 27-37.
Read now
Read now
Dejan Radovanovic, Marco Contoli, Fabiano Di Marco, Giovanni Sotgiu, Girolamo Pelaia, Fulvio Braido, Angelo Guido Corsico, Claudio Micheletto, Paola Rogliani, Nicola Scichilone, Laura Saderi, Pierachille Santus & Paolo Solidoro. (2019) Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:3-4, pages 215-226.
Read now
Read now
Articles from other publishers (23)
Jennifer K. Quint, Amnon Ariel & Peter J. Barnes. (2023) Rational use of inhaled corticosteroids for the treatment of COPD. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Marc Miravitlles, Kazuto Matsunaga & Michael Dreher. (2023) Stepwise management of COPD: What is next after bronchodilation?. Therapeutic Advances in Respiratory Disease 17.
Crossref
Crossref
Arwel W Jones, Joanne E McKenzie, Christian R Osadnik, Elizabeth Stovold, Narelle S Cox, Angela T Burge, Aroub Lahham, Joanna YT Lee, Mariana Hoffman & Anne E Holland. (2022) Non-pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta-analysis. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Crossref
Vijayamma AjmeraIqbal Mohammed SheikhSumant Kumar Dadhich. (2021) Effectiveness of demonstration on practice regarding pulmonary rehabilitation techniques among patients with chronic obstructive pulmonary disease in selected hospital at Udaipur city, Rajasthan.. International Journal of Nursing Education and Research, pages 403-406.
Crossref
Crossref
Krishna Sriram, Michael B. Insel & Paul A. Insel. (2022)
Inhaled
β
2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?
. Pharmacological Reviews 73:4, pages 1659-1697.
Crossref
Crossref
Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli & Marc Miravitlles. (2021) Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología 57:3, pages 205-213.
Crossref
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología (English Edition) 57:3, pages 205-213.
Crossref
Crossref
Daiana Stolz & Marc Miravitlles. (2020) The right treatment for the right patient with COPD: lessons from the IMPACT trial. European Respiratory Journal 55:5, pages 2000881.
Crossref
Crossref
María Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019. Archivos de Bronconeumología 56:2, pages 106-113.
Crossref
Crossref
Maria Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019. Archivos de Bronconeumología (English Edition) 56:2, pages 106-113.
Crossref
Crossref
Pietro Pirina, Elisabetta Zinellu, Marco Martinetti, Claudia Spada, Barbara Piras, Claudia Collu & Alessandro Giuseppe Fois. (2020) Treatment of COPD and COPD–heart failure comorbidity in primary care in different stages of the disease. Primary Health Care Research & Development 21.
Crossref
Crossref
Jürgen Knobloch, David Jungck, Juliane Kronsbein, Erich Stoelben, Kazuhiro Ito & Andrea Koch. (2019) LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD. Journal of Clinical Medicine 8:12, pages 2058.
Crossref
Crossref
Pierachille Santus, Matteo Pecchiari, Francesco Tursi, Vincenzo Valenti, Marina Saad & Dejan Radovanovic. (2019) The Airways’ Mechanical Stress in Lung Disease: Implications for COPD Pathophysiology and Treatment Evaluation. Canadian Respiratory Journal 2019, pages 1-8.
Crossref
Crossref
Sergey N. Avdeev & Natal’ya V. Trushenko. (2019) Triple therapy in chronic obstructive pulmonary disease. Russian Pulmonology 29:2, pages 199-206.
Crossref
Crossref
Peter J. Barnes. (2019) Inflammatory endotypes in COPD. Allergy 74:7, pages 1249-1256.
Crossref
Crossref
Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2019) Adding a LAMA to ICS/LABA Therapy. Chest 155:4, pages 758-770.
Crossref
Crossref
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid & Leonardo M. Fabbri. (2019) Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box. ERJ Open Research 5:1, pages 00185-2018.
Crossref
Crossref
Peter J Barnes. 2019. Genomic and Precision Medicine. Genomic and Precision Medicine
383
399
.
Roland SeifertRoland Seifert. 2019. Basic Knowledge of Pharmacology. Basic Knowledge of Pharmacology
181
193
.
Mario Cazzola, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2018)
Triple therapy
versus
single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
. European Respiratory Journal 52:6, pages 1801586.
Crossref
Crossref
V. V. Arkhipov. (2018) Prevention of copd exacerbations. Focus on dual bronchodilators. Medical Council:15, pages 8-17.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. Chest 154:2, pages 242-248.
Crossref
Crossref